logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

6 Biotech Stocks That Investors Hate but Analysts Love

  +Follow June 27, 2013 7:51PM
Share:
Tickers Mentioned:

Sometimes there are stocks that take a beating, but for whatever reason, the analysts won’t let them go. We decided to look at stocks that have had a rough go, but according to the analysts, are set to rebound any time. Specifically, for this article, we looked at the biotech sector.

Here’s the criteria we used: we decided to look at stocks that were down for the quarter but still had a “strong buy” rating from analysts. We further refined our search by focusing only on stocks above $4 a share to eliminate the more volatile ones.

We found six stocks that fit our criteria. Here they are:

Durata Therapeutics (DRTX) Chicago-based antibiotic developer Durata raised $74 million in an October 2012 IPO. Their main drug in development is dalbavancin, which treats skin infections. A December 2012 trial went well. Analysts still believe in the product’s future. Despite sitting near its 52 week low at $7 a share, Durata is up 1.74 percent.

Coronado Biosciences (CNDO) The immunotherapy drug development company is up 1.01 percent to $7.99 a share, and despite a dip the last few months, they’re up almost 67.58 percent on the year. Coronado recently announced they are hosting a conference looking for new investors.

Anacor Pharmaceuticals (ANAC) Anacor descirbes themselves as “hav(ing) discovered and advanced into clinical development several novel and proprietary boron-based product candidates.” They are up 4.34 percent to $5.53 a share. In June Anacor entered into a $45 million dollar term loan with Hercules Tech (HTGC.)

OncoGenex Pharmaceuticals (OGXI) OncoGenex gained 2.73 percent to hit $9.80 a share, though it’s down for the quarter and year (over 20 percent YTD.) Zacks is high on them, citing their drug OGX-011 that is “the lead candidate currently completing five Phase 2 clinical studies in prostate, lung and breast cancers.”

Lpath Inc. (LPTN) Lpath lost 1.94 percent to hit $4.56 a share, and is down for the year. This San Diego-based biotech company works on drugs that prevent macular degeneration. According to the New York Times, Lpath is advancing has completed a phase-I clinical trial for the drug ASONEP and is entering phase-II clinical trials in Renal Cell Carcinoma.

Array BioPharma(ARRY) Array is up 2.65 percent to hit $4.64 a share, down from their 52 week high of $6.56. Analysts are still bullish on the stock following promising trials for their p38 inhibitors that could have therapeutic effects on osteoarthritis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for DRTX
Market News
29 Aug 14 00:15:22
$DRTX: Nasdaq stocks posting largest percentage decreases http://t.co/YIIxALRcNR http://t.co/QdCbpKow7D
monestsignalen
29 Aug 14 00:10:03
#aandelen strong stocks die verliezen - http://t.co/aHvH1mxjZd $DRTX $GTAT $ARWR
Equities.com
28 Aug 14 19:17:45
Durata Therapeutics Inc. (DRTX) Drops 5.88% on August 28 $DRTX http://t.co/XJYUpcwBGA
Matilda Begay
28 Aug 14 16:48:59
$DRTX Nasdaq stocks posting http://t.co/zFM0SccKxm
Stockaholics
28 Aug 14 15:57:44
$VIIC ran up 720% Today in an explosive move! Our new picks are coming soon: http://t.co/EdxLh9u5Nx $DRTX $VIPS $XRA
Stockaholics
28 Aug 14 15:42:38
$VIIC ran up 720% Today in an explosive move! Our new picks are coming soon: http://t.co/EdxLh9u5Nx $SRGE $BEST $DRTX
Market News
28 Aug 14 11:15:24
$DRTX: Nasdaq stocks posting largest percentage decreases http://t.co/bFPgjg5QXj http://t.co/UIpbbDTVwY
ChartMill
28 Aug 14 10:34:03
new strong stocks losing http://t.co/H7Pqssmy3j #stocks $LVNTA $WSM $DRTX
Joseph M Swartz
28 Aug 14 10:28:10
$DRTX - Statement of Changes in Beneficial Ownership (4) http://t.co/uxfgvuLHzi
VisualStock Resource
28 Aug 14 10:28:09
$DRTX - Statement of Changes in Beneficial Ownership (4) http://t.co/1j7iGJ676G
karmaswimswami
28 Aug 14 10:24:28
New insider buying at $DRTX
Joseph M Swartz
28 Aug 14 10:22:09
$DRTX - Initial Statement of Beneficial Ownership (3) http://t.co/EQbGwDUuhz
VisualStock Resource
28 Aug 14 10:22:07
$DRTX - Initial Statement of Beneficial Ownership (3) http://t.co/OsEvTKhhuL
Joseph M Swartz
28 Aug 14 10:19:11
$DRTX - Statement of Changes in Beneficial Ownership (4) http://t.co/UGV8QOi4ZB
VisualStock Resource
28 Aug 14 10:19:09
$DRTX - Statement of Changes in Beneficial Ownership (4) http://t.co/kKdnuUD429
Joseph M Swartz
28 Aug 14 10:16:45
$DRTX - Initial Statement of Beneficial Ownership (3) http://t.co/y4wYcR0NQJ
VisualStock Resource
28 Aug 14 10:16:43
$DRTX - Initial Statement of Beneficial Ownership (3) http://t.co/gB2qdD3NUU
$Stocknewsalerts
28 Aug 14 10:14:21
$DRTX SEC Filing Alert for Durata Therapeutics, Inc. From our Stock News Alerts App
Financial Updates
28 Aug 14 07:15:23
$DRTX: DURATA THERAPEUTICS, INC. Financials http://t.co/FcfKDthye4 http://t.co/cYg2PSXwoP
mHealth Reporter
28 Aug 14 06:15:33
RT @BV_Healthcare: $DRTX Durata Therapeutics, Inc files Form 8-K (Events or Changes Between Quarterly Reports) SEC Filing.. http://t.co/9FW…
Business News Watch
28 Aug 14 06:15:28
$DRTX: Durata Therapeutics Reports Second Quarter 2014 Financial Results http://t.co/7QJTwECmiJ http://t.co/SMrY0bMFnT
Joseph M Swartz
28 Aug 14 06:15:19
$DRTX - Current Report Filing (8-k) http://t.co/iNP0wwmYnx
Joseph M Swartz
28 Aug 14 06:15:18
$DRTX - Current Report Filing (8-k) http://t.co/1L7IMVdmBu
VisualStock Resource
28 Aug 14 06:15:16
$DRTX - Current Report Filing (8-k) http://t.co/4buWPIdkr9
VisualStock Resource
28 Aug 14 06:15:15
$DRTX - Current Report Filing (8-k) http://t.co/5FWYr6Vjhu
BV Healthcare
28 Aug 14 06:11:11
$DRTX Durata Therapeutics, Inc files Form 8-K (Events or Changes Between Quarterly Reports) SEC Filing.. http://t.co/9FWe6By8AX
$Stocknewsalerts
28 Aug 14 06:05:45
$DRTX SEC Filing Alert for Durata Therapeutics, Inc. From our Stock News Alerts App
BV Healthcare
28 Aug 14 06:05:04
$DRTX Durata Therapeutics, Inc files Form 8-K (Events or Changes Between Quarterly Reports) SEC Filing.. http://t.co/m9pdGrzDLd
Norah Keys
27 Aug 14 06:43:14
$DRTX DURATA THERAPEUTICS, INC. Files SEC form 8-K, Entry i http://t.co/9oYOgPnsky
Small Cap Strategist
26 Aug 14 16:40:17
Most searched small-cap stocks, Tues Aug 26th - $SWHC $TASR $ISNS $MTSL $DRTX $BDSI $TRUE $PLNR - More: http://t.co/rXjeuoBOGl - #smallcap
Stock News Guru
26 Aug 14 15:15:23
$DRTX: What Makes Durata Therapeutics (DRTX) a Strong Sell? - Tale of the Tape http://t.co/eF1kcz1Y4N http://t.co/nHJJl9fQU8
MAISA
26 Aug 14 14:59:33
$DRTX Names Wendy Yarno and J. Martin Carroll to Its Board of Directors
$Stocknewsalerts
26 Aug 14 14:56:48
$DRTX Durata Therapeutics Names Wendy Yarno and J. Martin Carroll to Its Board of Directors From our Stock News Alerts App
BV Healthcare
26 Aug 14 14:00:43
$DRTX Durata Therapeutics Names Wendy Yarno and J. Martin Carroll to Its Board of Directors.. http://t.co/YV0h0mYcwz
BV Healthcare
26 Aug 14 14:00:26
$DRTX Durata Therapeutics Names Wendy Yarno and J. Martin Carroll to Its Board of Directors.. http://t.co/JnzqE3rJeR
Alexander Morris
26 Aug 14 11:20:34
$DRTX: Exc 1MoHIGH=16.75, hits:1, Rng:25%, ch:+2.4%, 0phNewHi:BrkPLo[+202.2%], 2:1Accel+, tf:7f, LowFlt[9.8M], HiPctSht[29%:5d]
Harry Boxer
26 Aug 14 07:17:52
From our Charts of Day video (targets parens): $ACHN (11 1/4) $BDSI (14.44, 18) $DRTX (171/4, 181/4) $KERX (21) http://t.co/HTmDSy8FDK
Financial Headlines
26 Aug 14 07:15:26
$DRTX: Durata Therapeutics PT Lowered to $12.00 (DRTX) http://t.co/dwIHih2OkY http://t.co/U4lLWElxOb
Stock Market Monitor
26 Aug 14 06:15:28
$DRTX: Stock Traders Buy Large Volume of Durata Therapeutics Put Options (DRTX) http://t.co/4wzCk8Z3Ia http://t.co/jw2YTiOCQS
Market Headlines
26 Aug 14 05:15:24
$DRTX: Durata Therapeutics (DRTX) Worth Watching: Stock Gains 18.5% http://t.co/XtuktzCinz http://t.co/sHd3XftTFd
Don Fishback
26 Aug 14 04:49:34
1 Day Decrease in ATM IV (Point change) $DRTX, $AXDX, $KING, $AIRM, $EXPR http://t.co/ngVz9it0jz
OptionApps
26 Aug 14 04:49:34
1 Day Decrease in ATM IV (Point change) $DRTX, $AXDX, $KING, $AIRM, $EXPR http://t.co/r1mOye1q98
TickerChirp
25 Aug 14 22:38:05
Popular Tweets About $DRTX on 08/26/2014 http://t.co/m55MrS66Ht
Alexander Morris
25 Aug 14 06:31:49
$DRTX: Exc 1MoHIGH=16.24, hits:1, Rng:23%, ch:+1.6%, PrvCHi, 2:1Accel+, tf:7f, LowFlt[9.8M], HiPctSht[29%:6d], DyVol:3T:0x:0x
				
				
  +Follow June 27, 2013 7:51PM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.